These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 641915

  • 1. Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis.
    Berglöf FE, Berglöf K, Walz DT.
    J Rheumatol; 1978; 5(1):68-74. PubMed ID: 641915
    [Abstract] [Full Text] [Related]

  • 2. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC, Osborn TG.
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [Abstract] [Full Text] [Related]

  • 3. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE, Roisman FR, Batista V, de Nudelman FG, de Titto EH, Mizraji M, Walz DT.
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [Abstract] [Full Text] [Related]

  • 4. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
    Atakhodzhaeva ZA, Sigidin IaA.
    Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
    [Abstract] [Full Text] [Related]

  • 5. Chrysotherapy: a synoptic review.
    Eisler R.
    Inflamm Res; 2003 Dec; 52(12):487-501. PubMed ID: 14991077
    [Abstract] [Full Text] [Related]

  • 6. [The pharmacology of gold compounds].
    Juan H.
    Wien Klin Wochenschr Suppl; 1984 Dec; 156():7-13. PubMed ID: 6442062
    [Abstract] [Full Text] [Related]

  • 7. Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates.
    Gottlieb NL.
    J Rheumatol Suppl; 1979 Dec; 5():51-5. PubMed ID: 114649
    [Abstract] [Full Text] [Related]

  • 8. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM, Storck U.
    Schweiz Med Wochenschr; 1985 Dec 07; 115(49):1775-7. PubMed ID: 3937234
    [Abstract] [Full Text] [Related]

  • 9. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
    Tosi S, Cagnoli M, Guidi G, Murelli M, Messina K, Colombo B.
    Int J Clin Pharmacol Res; 1985 Dec 07; 5(4):265-8. PubMed ID: 2932399
    [Abstract] [Full Text] [Related]

  • 10. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA, Kanevskaia MZ, Krel' AA, Chichasova NV.
    Revmatologiia (Mosk); 1989 Dec 07; (1):8-16. PubMed ID: 2501852
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS, Saeed M, Taqi SG.
    Biol Trace Elem Res; 2008 Dec 07; 126(1-3):56-64. PubMed ID: 18649049
    [Abstract] [Full Text] [Related]

  • 12. An analysis of worldwide safety experience with auranofin.
    Heuer MA, Pietrusko RG, Morris RW, Scheffler BJ.
    J Rheumatol; 1985 Aug 07; 12(4):695-9. PubMed ID: 3932651
    [Abstract] [Full Text] [Related]

  • 13. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M.
    Wien Klin Wochenschr Suppl; 1984 Aug 07; 156():3-7. PubMed ID: 6442054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ulcerative colitis caused by oral gold therapy in rheumatoid arthritis].
    Bross-Bach U, Saal JG, Hartmann F, Müller CA, Waller HD.
    Z Rheumatol; 1987 Aug 07; 46(4):201-4. PubMed ID: 3118590
    [Abstract] [Full Text] [Related]

  • 17. Auranofin.
    Davis P.
    Clin Rheum Dis; 1984 Aug 07; 10(2):369-83. PubMed ID: 6239742
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K, Zbojanová M.
    Cas Lek Cesk; 1982 Nov 11; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacology of auranofin: overview and update.
    Gottlieb NL.
    Scand J Rheumatol Suppl; 1986 Nov 11; 63():19-28. PubMed ID: 3110942
    [Abstract] [Full Text] [Related]

  • 20. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
    Giannini EH, Barron KS, Spencer CH, Person DA, Baum J, Bernstein BH, Kredich DW, Jacobs JC, Zemel LS, Gibbas D.
    J Rheumatol; 1991 Aug 11; 18(8):1240-2. PubMed ID: 1941832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.